Dear All,
Forwarding you the Result Flash on Dishman Pharma for 4QFY2011.
4QFY2011 Financials Snapshot
| Y/E March (`cr) | 4QFY2011 | 3QFY2011 | % chg qoq | 4QFY2010 | % chg yoy |
| Net sales | 344 | 232 | 48.6 | 248 | 38.9 |
| Other income | 3 | 6 | (43.9) | 3 | 4.1 |
| Operating profit | 55 | 25 | 118.9 | 49 | 12.1 |
| Interest | 10 | 13 | (21.4) | 10 | 4.7 |
| Net profit | 22 | 2 | 1,140.5 | 21 | 4.4 |
4QFY2011 Financials Actuals v/s Estimates
| Rs cr | Actual | Estimates | Variation |
| Net Sales | 344 | 266 | 29.7 |
| Other Income | 3 | (14) | (124.6) |
| Operating Profit | 55 | 52 | 5.8 |
| Interest | 10 | 8 | 38.9 |
| Tax | 7 | 5 | 40.7 |
| Net Profit | 22 | 2 | 1,313.7 |
4QFY2011 Consolidated Financial Result Highlights-
· The Company has reported net sales of `344cr (`248cr), increase of 38.9%, higher than our estimates of `266cr.
· The gross margins reported a drop to 54.9% (59%) lower than our estimates of 63.0%. This translated into drop in the OPM to 16.1% (20%), lower than our estimate of 19.7%.
· The company reported the net profit at `23cr (`21cr), growth of 9.7% yoy, higher than our estimates of `1.5cr. The adjusted net profit grew by 4.4% to `21.6cr (`20.7cr).
· For the full year, the net sales grew by 8.2% yoy to `990.8cr (`915.4cr). The OPM came in at 16.4% (22.2%). The adjusted net profit dropped by 31.8% to `80cr (`117.4cr). On the segmental performance, the CRAMS division de-grew by 1.2% whereas the MM business clocked growth of 33.2% yoy.
4QFY2011 Consolidated Financial Performance:
| Y/E March (`cr) | 4QFY2011 | 3QFY2011 | % chg qoq | 4QFY2010 | % chg yoy | FY2011 | FY2010 | % chg |
| Net sales | 344 | 232 | 48.6 | 248 | 38.9 | 991 | 915 | 8.2 |
| Other income | 3 | 6 | (43.9) | 3 | 4.1 | 40 | 28 | 44.6 |
| Total income | 348 | 238 | 46.2 | 251 | 38.5 | 1,031 | 943 | 9.3 |
| Gross profit | 189 | 148 | 27.8 | 146 | 29.4 | 691 | 639 | 8.2 
Subscribe to:
Post Comments (Atom)
|
No comments:
Post a Comment